COMPOSITIONS AND METHODS FOR ANXIETY DISORDER TREATMENT

Provided herein are compositions comprising an alkaloid compound of formula (I) having the structure: (I) wherein R1 is H or CH3, and R2 is H or PO3H2; or pharmaceutically acceptable salt thereof in combination with a therapeutically effective amount of crocin. Such compositions may be useful in tre...

Full description

Saved in:
Bibliographic Details
Main Authors COFT, KEVIN, SAAD, FADIA, PERRY, ROSE
Format Patent
LanguageEnglish
French
Published 30.06.2022
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Provided herein are compositions comprising an alkaloid compound of formula (I) having the structure: (I) wherein R1 is H or CH3, and R2 is H or PO3H2; or pharmaceutically acceptable salt thereof in combination with a therapeutically effective amount of crocin. Such compositions may be useful in treatment of anxiety disorder. Further provided herein are methods for treatment of anxiety disorder comprising administering to a patient in need thereof a therapeutically effective amount of an alkaloid compound having the structure: (I) wherein R1 is H or CH3, and R2 is H or PO3H2; or pharmaceutically acceptable salt thereof in combination with a therapeutically effective amount of crocin. Optionally, the amounts are synergistic and together provide an enhanced therapeutic effect. L'invention concerne des compositions comprenant un composé alcaloïde de formule (I) ayant la structure : (I) dans laquelle R1 représente H ou CH3, et R2 représente H ou PO3H2 ; ou un sel pharmaceutiquement acceptable de celui-ci en association avec une quantité thérapeutiquement efficace de crocine. De telles compositions peuvent être utiles dans le traitement du trouble de l'anxiété. L'invention concerne en outre des méthodes de traitement d'un trouble de l'anxiété consistant à administrer à un patient qui en a besoin une quantité thérapeutiquement efficace d'un composé alcaloïde ayant la structure : (I) dans laquelle R1 représente H ou CH3, et R2 représente H ou PO3H2 ; ou un sel pharmaceutiquement acceptable de celui-ci en association avec une quantité thérapeutiquement efficace de crocine. Facultativement, les quantités sont synergiques et fournissent conjointement un effet thérapeutique amélioré.
AbstractList Provided herein are compositions comprising an alkaloid compound of formula (I) having the structure: (I) wherein R1 is H or CH3, and R2 is H or PO3H2; or pharmaceutically acceptable salt thereof in combination with a therapeutically effective amount of crocin. Such compositions may be useful in treatment of anxiety disorder. Further provided herein are methods for treatment of anxiety disorder comprising administering to a patient in need thereof a therapeutically effective amount of an alkaloid compound having the structure: (I) wherein R1 is H or CH3, and R2 is H or PO3H2; or pharmaceutically acceptable salt thereof in combination with a therapeutically effective amount of crocin. Optionally, the amounts are synergistic and together provide an enhanced therapeutic effect. L'invention concerne des compositions comprenant un composé alcaloïde de formule (I) ayant la structure : (I) dans laquelle R1 représente H ou CH3, et R2 représente H ou PO3H2 ; ou un sel pharmaceutiquement acceptable de celui-ci en association avec une quantité thérapeutiquement efficace de crocine. De telles compositions peuvent être utiles dans le traitement du trouble de l'anxiété. L'invention concerne en outre des méthodes de traitement d'un trouble de l'anxiété consistant à administrer à un patient qui en a besoin une quantité thérapeutiquement efficace d'un composé alcaloïde ayant la structure : (I) dans laquelle R1 représente H ou CH3, et R2 représente H ou PO3H2 ; ou un sel pharmaceutiquement acceptable de celui-ci en association avec une quantité thérapeutiquement efficace de crocine. Facultativement, les quantités sont synergiques et fournissent conjointement un effet thérapeutique amélioré.
Author SAAD, FADIA
PERRY, ROSE
COFT, KEVIN
Author_xml – fullname: COFT, KEVIN
– fullname: SAAD, FADIA
– fullname: PERRY, ROSE
BookMark eNrjYmDJy89L5WQwd_b3DfAP9gzx9PcLVnD0c1HwdQ3x8HcJVnDzDwLyIzxdQyIVXDyD_YNcXIMUQoJcHUN8Xf1CeBhY0xJzilN5oTQ3g4Kba4izh25qQX58anFBYnJqXmpJvLOjsZGBkZmBhaOhMRFKAA_LKbM
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate COMPOSITIONS DE PSIL3301-4-2 ET METHODES DE TRAITEMENT DE TROUBLES DE L'ANXIETE
ExternalDocumentID CA3202608A1
GroupedDBID EVB
ID FETCH-epo_espacenet_CA3202608A13
IEDL.DBID EVB
IngestDate Fri Aug 09 05:01:35 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_CA3202608A13
Notes Application Number: CA20213202608
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220630&DB=EPODOC&CC=CA&NR=3202608A1
ParticipantIDs epo_espacenet_CA3202608A1
PublicationCentury 2000
PublicationDate 20220630
PublicationDateYYYYMMDD 2022-06-30
PublicationDate_xml – month: 06
  year: 2022
  text: 20220630
  day: 30
PublicationDecade 2020
PublicationYear 2022
RelatedCompanies PSILOBRAIN THERAPEUTICS INC
RelatedCompanies_xml – name: PSILOBRAIN THERAPEUTICS INC
Score 3.4032829
Snippet Provided herein are compositions comprising an alkaloid compound of formula (I) having the structure: (I) wherein R1 is H or CH3, and R2 is H or PO3H2; or...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title COMPOSITIONS AND METHODS FOR ANXIETY DISORDER TREATMENT
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220630&DB=EPODOC&locale=&CC=CA&NR=3202608A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp-L8Ig_St-KWdun2UKRLMlqhH2xV5tNI1w720g1X8d_3Urfpi77lA47k4JfLJfe7A3iwHGfeWSjLtHKWmXbhKDNTXQSeRfOMUcWY0mzkMGL-i_087U0bsNxxYeo8oZ91ckRE1BzxXtXn9frnEUvUsZWbx2yJQ6unUeoKY-sdU6pTSBli6MokFjE3OHe5Z0RjV5cJZ52-h47SAd6iHQ0G-TrUpJT1b4syOoXDBIWV1Rk0irIFx3xXeK0FR-H2vxubW-htzsHhcZjEk6Cm_RIvEiSUqR-LCUE_DvvTQKZvRAQT9OrkmKRj6aU6Uf8FkJFMuW_iCmb73c64t1-rdQnNclUWV0BUTgfFok-7qlA26k9RlmssDtAgW7Zjt6H9p5jrf-Zu4ESr7TsC7haa1ftHcYdmtsruawV9Ack2fDA
link.rule.ids 230,309,783,888,25576,76882
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8QNOKbokb87IPZ2yJssxsPixldyaZsI1ANPpGOjYSXQWTGf9_rBPRF3_qRXNpLfr1ee787gDvTtmftuTR1M6OpbuW21FPZQeCZRpZSQ1IqFRs5imnwYj1NHiY1WGy5MFWe0M8qOSIiaoZ4L6vzevXziOVXsZXr-3SBQ8vHvnB9beMdG4ZKIaX5PZcPEz9hGmMu87R45Koy4bTteOgo7eEN21HFDvhrT5FSVr8tSv8I9ocorCiPoZYXTWiwbeG1JhxEm_9ubG6gtz4BmyXRMBmHFe2XeLFPIi6CxB8T9OOwPwm5eCN-OEavjo-IGHFPqET9p0D6XLBAxxVMd7udMm-3VvMM6sWyyM-ByMzo5nPH6MhcWqg_adBMYbGLBtm0bKsFrT_FXPwzdwuNQESD6SCMny_hUKnwOxruCurl-0d-jSa3TG8qZX0Bw_h_IA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=COMPOSITIONS+AND+METHODS+FOR+ANXIETY+DISORDER+TREATMENT&rft.inventor=COFT%2C+KEVIN&rft.inventor=SAAD%2C+FADIA&rft.inventor=PERRY%2C+ROSE&rft.date=2022-06-30&rft.externalDBID=A1&rft.externalDocID=CA3202608A1